Who are Open label H.P. Acthar Gel's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): H.P. Acthar Gel.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/open-label-h-p-acthar-gel.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Open label H.P. Acthar Gel — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Open label H.P. Acthar Gel (Open label H.P. Acthar Gel) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Corticotropin (ACTH analog). Area: Immunology / Rheumatology / Neurology.

marketed Corticotropin (ACTH analog) Melanocortin-2 receptor (MC2R) Immunology / Rheumatology / Neurology Small molecule Live · refreshed every 30 min

Target snapshot

Open label H.P. Acthar Gel (Open label H.P. Acthar Gel) — Fiechtner, Justus J., M.D., P.C.. H.P. Acthar Gel is a corticotropin (ACTH) preparation that stimulates the adrenal cortex to produce and release cortisol and other corticosteroids.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Open label H.P. Acthar Gel TARGET	Open label H.P. Acthar Gel	Fiechtner, Justus J., M.D., P.C.	marketed	Corticotropin (ACTH analog)	Melanocortin-2 receptor (MC2R)
H.P. Acthar Gel	H.P. Acthar Gel	Fiechtner, Justus J., M.D., P.C.	marketed	Corticotropin (ACTH analog)	Melanocortin-2 receptor (MC2R)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Corticotropin (ACTH analog) class)

Fiechtner, Justus J., M.D., P.C. · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Open label H.P. Acthar Gel — Competitive Intelligence Brief. https://druglandscape.com/ci/open-label-h-p-acthar-gel. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab